ロード中...
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not di...
保存先:
| 出版年: | J Immunother Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7264828/ https://ncbi.nlm.nih.gov/pubmed/32474415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000742 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|